NO962720L - Kappa-opiatagonister for inflammatoriske tarmsykdommer - Google Patents

Kappa-opiatagonister for inflammatoriske tarmsykdommer

Info

Publication number
NO962720L
NO962720L NO962720A NO962720A NO962720L NO 962720 L NO962720 L NO 962720L NO 962720 A NO962720 A NO 962720A NO 962720 A NO962720 A NO 962720A NO 962720 L NO962720 L NO 962720L
Authority
NO
Norway
Prior art keywords
inflammatory bowel
bowel disease
opiate agonists
kappa opiate
kappa
Prior art date
Application number
NO962720A
Other languages
English (en)
Other versions
NO962720D0 (no
NO309674B1 (no
Inventor
Andrew Barber
Christoph Seyfried
Gerd Bartoszyk
Rudolf Gottschlich
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO962720D0 publication Critical patent/NO962720D0/no
Publication of NO962720L publication Critical patent/NO962720L/no
Publication of NO309674B1 publication Critical patent/NO309674B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO962720A 1995-06-28 1996-06-27 Anvendelse av N-metyl-N-[(1S)-1-fenyl-2-((3S)-3- hydroksypyrrolidin-1-yl)-etyl]-2,2-difenylacetamid til fremstilling av legemiddelpreparater for behandling av inflammatoriske tarmsykdommer NO309674B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19523502A DE19523502A1 (de) 1995-06-28 1995-06-28 Kappa-Opiatagonisten für entzündliche Darmerkrankungen

Publications (3)

Publication Number Publication Date
NO962720D0 NO962720D0 (no) 1996-06-27
NO962720L true NO962720L (no) 1996-12-30
NO309674B1 NO309674B1 (no) 2001-03-12

Family

ID=7765475

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962720A NO309674B1 (no) 1995-06-28 1996-06-27 Anvendelse av N-metyl-N-[(1S)-1-fenyl-2-((3S)-3- hydroksypyrrolidin-1-yl)-etyl]-2,2-difenylacetamid til fremstilling av legemiddelpreparater for behandling av inflammatoriske tarmsykdommer

Country Status (26)

Country Link
US (2) US5776972A (no)
EP (1) EP0752246B1 (no)
JP (2) JP4415075B2 (no)
KR (1) KR100501612B1 (no)
CN (1) CN1119147C (no)
AR (1) AR004671A1 (no)
AT (1) ATE214275T1 (no)
AU (1) AU708699B2 (no)
BR (1) BR9602915A (no)
CA (1) CA2179955C (no)
CO (1) CO4700454A1 (no)
CZ (1) CZ289805B6 (no)
DE (2) DE19523502A1 (no)
DK (1) DK0752246T3 (no)
ES (1) ES2171577T3 (no)
HU (1) HU226976B1 (no)
NO (1) NO309674B1 (no)
PL (1) PL185537B1 (no)
PT (1) PT752246E (no)
RU (1) RU2190401C2 (no)
SI (1) SI0752246T1 (no)
SK (1) SK283497B6 (no)
TR (1) TR199600497A2 (no)
TW (1) TW430557B (no)
UA (1) UA51615C2 (no)
ZA (1) ZA965480B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6303611B1 (en) * 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
ATE235903T1 (de) * 1996-12-02 2003-04-15 Kyorin Seiyaku Kk Neue derivate von n-substituierten pyrrolidin derivaten und deren herstellungsverfahren
US6133307A (en) * 1997-04-30 2000-10-17 Warner-Lambert Company Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
MXPA99011298A (es) * 1997-07-14 2004-10-28 Adolor Corp Formulaciones farmaceuticas antiprurito de agonista kappa y metodo para tratar prurito con las mismas.
DE19827633A1 (de) * 1998-04-20 1999-10-21 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
US20050176746A1 (en) * 2002-05-17 2005-08-11 Frank Weber Use of compounds that are effective as selective opiate receptor modulators
WO2004039785A1 (en) * 2002-11-01 2004-05-13 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
WO2005002622A1 (ja) * 2003-07-04 2005-01-13 Santen Pharmaceutical Co., Ltd. 疼痛閾値低下抑制剤
US7642274B2 (en) 2003-07-04 2010-01-05 Santen Pharmaceutical Co., Ltd. Inhibitor of pain threshold decrease
US20080090859A1 (en) * 2003-10-30 2008-04-17 Tioga Pharmaceuticals, Inc. Use of Selective Opiate Receptor Modulators In the Treatment Of Neuropathy
US7160902B2 (en) * 2003-11-14 2007-01-09 Adolor Corporation Amide derivatives and methods of their use
CN101677997B (zh) * 2007-03-30 2012-05-09 泰奥加制药公司 用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
US9487510B2 (en) 2012-03-05 2016-11-08 Dr. Reddy's Laboratories Ltd. Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
EA201691489A1 (ru) * 2014-01-24 2016-12-30 Кадила Хелзкэр Лимитед Новые гетероциклические соединения в качестве агонистов каппа-опиодиов
EP3558300B1 (en) 2016-12-21 2021-11-24 Tioga Pharmaceuticals, Inc. Solid pharmaceutical formulations of asimadoline
WO2019122361A1 (en) 2017-12-22 2019-06-27 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Asimadoline for use in treating pulmonary diseases, vascular diseases, and sepsis
EP3932390A1 (en) 2020-07-02 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical gel formulation containing asimadoline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663343A (en) * 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US5232266A (en) * 1989-07-24 1993-08-03 Mork William J Upholstered article of furniture with interchangeable seating module
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide

Also Published As

Publication number Publication date
JP4415075B2 (ja) 2010-02-17
HUP9601798A1 (hu) 1998-03-30
PL185537B1 (pl) 2003-05-30
JP5308056B2 (ja) 2013-10-09
CZ289805B6 (cs) 2002-04-17
TW430557B (en) 2001-04-21
NO962720D0 (no) 1996-06-27
RU2190401C2 (ru) 2002-10-10
PT752246E (pt) 2002-09-30
ATE214275T1 (de) 2002-03-15
AR004671A1 (es) 1999-03-10
NO309674B1 (no) 2001-03-12
UA51615C2 (uk) 2002-12-16
PL314996A1 (en) 1997-01-06
EP0752246B1 (de) 2002-03-13
CN1145781A (zh) 1997-03-26
CZ186696A3 (en) 1997-01-15
CA2179955A1 (en) 1996-12-29
CN1119147C (zh) 2003-08-27
EP0752246A3 (de) 1997-02-26
ES2171577T3 (es) 2002-09-16
JP2008201794A (ja) 2008-09-04
ZA965480B (en) 1997-01-27
AU708699B2 (en) 1999-08-12
SI0752246T1 (en) 2002-10-31
CA2179955C (en) 2008-10-07
US5776972A (en) 1998-07-07
AU5616296A (en) 1997-01-09
SK283497B6 (sk) 2003-08-05
DE59608861D1 (de) 2002-04-18
US5977161A (en) 1999-11-02
BR9602915A (pt) 1998-04-22
HU226976B1 (en) 2010-04-28
CO4700454A1 (es) 1998-12-29
DK0752246T3 (da) 2002-05-13
KR100501612B1 (ko) 2005-10-12
TR199600497A2 (tr) 1997-01-21
JPH0920659A (ja) 1997-01-21
EP0752246A2 (de) 1997-01-08
DE19523502A1 (de) 1997-01-02
SK84396A3 (en) 1997-04-09
KR970000230A (ko) 1997-01-21

Similar Documents

Publication Publication Date Title
NO962720L (no) Kappa-opiatagonister for inflammatoriske tarmsykdommer
DE69618374D1 (de) Koaxialverbinder
NO974387L (no) Gjengeforbindelse for rör
NO961647L (no) Gjengeforbindelse for rör
NO981281D0 (no) Forbedringer vedrörende rörrensing
NO961887D0 (no) -adrenergiske agonister
DE69605623D1 (de) Mehrschichtrohr
DE69611368D1 (de) Oligonukleotide spezifisch für humane papillomaviren
ID18917A (id) Proses untuk sintesis benzotiofena
DE59601221D1 (de) Langgestreckte rohrförmige Hülle
DE69634464D1 (de) Cachespeicher
FR2737755B3 (fr) Raccord perfectionne pour structures tubulaires
DE69613264D1 (de) Reinigungseinheit für Verzugszylinder
IS1809B (is) Kasttrekt fyrir fiskilínu
ID26842A (id) Proses untuk membuat klorobenzoksazola
KR970002339U (ko) 파이프용 분기관
DE69634465D1 (de) Cachespeicher
ID21349A (id) Proses untuk sintesis benzotiophena
AT1078U3 (de) Halterung für tuben
KR970006372U (ko) 배수로관
ID23162A (id) Proses untuk mendekomposisi sikloalkilhidroperoksida
KR970049204U (ko) 파이프 벤딩기
KR960034274U (ko) 파이프 홀더구조
KR970060916U (ko) 소형파이프류의 굽힘기
KR970024447U (ko) 파이프 홀더